Virag Sharon 4
4 · NEOGENOMICS INC · Filed Mar 5, 2019
Insider Transaction Report
Form 4
Virag Sharon
Chief Financial Officer
Transactions
- Award
Common Stock
2019-03-01+10,944→ 10,944 total - Award
Stock Option (Right to Buy)
2019-03-01$19.60/sh+66,897$1,311,181→ 66,897 totalExercise: $19.60From: 2020-03-01Exp: 2024-03-01→ Common Stock (66,897 underlying)
Holdings
- 192,500
Stock Option (Right to Buy)
Exercise: $8.22From: 2019-03-27Exp: 2023-03-27→ Common Stock (192,500 underlying)
Footnotes (2)
- [F1]On March 1, 2019, Ms. Virag was granted an option to purchase shares of NeoGenomics, Inc. common stock. The option vests ratably over the first four anniversary dates of the grant date.
- [F2]On March 27, 2018, Ms. Virag was granted an option to purchase shares of NeoGenomics, Inc. common stock. The option vests ratably over the first three anniversary dates of the grant date.